ARCHIVES

PV-10 Produces 51 Percent Response Rate in Phase II Trial

This article is from The Cancer Letter archive.

Vol. 35 No. 10 | October 26, 2012

Download PDF Visit The Full Archive

Related Articles

Clearinghouse Subgroup Okeys Carcinogenesis Testing for Anticancer Drugs

September 8, 1978

Bill Reintroduced to Weaken U.S. Preventive Services Task Force

July 3, 2013

ODAC Recommendation for Pertuzumab Signals FDA’s Resolve In Granting Accelerated Approvals

September 20, 2013

Blumenthal Says Action Plan To Issue “New Priority Areas”

October 24, 1996

NCI Review Groups Merged Into One Umbrella Group

November 17, 1995

ProPAC Calls For Adjustments In For Tobacco Advertising Ban

July 25, 1986